Ocular Therapeutix Inc (OCUL)
5.215
-0.64
(-10.85%)
USD |
NASDAQ |
Apr 19, 16:00
5.215
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Total Assets (Quarterly): 252.06M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 252.06M |
| September 30, 2023 | 162.38M |
| June 30, 2023 | 122.56M |
| March 31, 2023 | 128.57M |
| December 31, 2022 | 149.29M |
| September 30, 2022 | 158.58M |
| June 30, 2022 | 173.07M |
| March 31, 2022 | 187.62M |
| December 31, 2021 | 204.89M |
| September 30, 2021 | 217.74M |
| June 30, 2021 | 230.71M |
| March 31, 2021 | 243.04M |
| December 31, 2020 | 261.86M |
| September 30, 2020 | 98.22M |
| June 30, 2020 | 107.26M |
| March 31, 2020 | 72.86M |
| December 31, 2019 | 78.74M |
| September 30, 2019 | 88.71M |
| June 30, 2019 | 89.74M |
| March 31, 2019 | 101.49M |
| December 31, 2018 | 73.04M |
| Date | Value |
|---|---|
| September 30, 2018 | 70.27M |
| June 30, 2018 | 70.46M |
| March 31, 2018 | 76.68M |
| December 31, 2017 | 55.43M |
| September 30, 2017 | 64.40M |
| June 30, 2017 | 79.68M |
| March 31, 2017 | 90.70M |
| December 31, 2016 | 74.94M |
| September 30, 2016 | 82.35M |
| June 30, 2016 | 89.90M |
| March 31, 2016 | 100.43M |
| December 31, 2015 | 110.31M |
| September 30, 2015 | 119.32M |
| June 30, 2015 | 129.47M |
| March 31, 2015 | 71.50M |
| December 31, 2014 | 78.19M |
| September 30, 2014 | 83.88M |
| June 30, 2014 | 23.97M |
| March 31, 2014 | 15.08M |
| December 31, 2013 | 19.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
72.86M
Minimum
Mar 2020
261.86M
Maximum
Dec 2020
159.36M
Average
158.58M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Assertio Holdings Inc | 286.42M |
| CytomX Therapeutics Inc | 201.79M |
| Regeneron Pharmaceuticals Inc | 33.08B |
| Cormedix Inc | 82.06M |
| Verastem Inc | 149.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 160.93M |
| Shareholders Equity (Quarterly) | 91.13M |
| Debt to Equity Ratio | 0.8222 |
| Current Ratio | 6.655 |
| Net Debt Paydown Yield | -0.84% |